H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Census population 413,066. Oklahoma Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Tulsa clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Tulsa storefront.
Biodynamic Hematogel Wound Care in Tulsa, OK for clinics & physicians. Biodynamic hematogel achieves 96.5%… Compliance support & pricing — contact Hawk Medical.
Tulsa is a city of 250k–500k (413,066 Census). CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Adult arthritis here is 25.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Biodynamic Hematogel Wound Care notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Adult obesity in Tulsa is 37.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 25.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, TX. Oklahoma State Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy biodynamic hematogel elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 12.8% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 12.8% of adults — 0.8 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 25.1%. That is place-level BRFSS modeling, not a clinic census and not a Tulsa trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Tulsa clinic. Ask for the bank’s registration and AATB status on the SKU you want.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
If you operate in Oklahoma and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Tulsa tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Tulsa, OK.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Tulsa is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Tulsa — 0.8 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Oklahoma Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Tulsa. Useful for joint-program math; still needs a diagnosis and privileging.
No Tulsa storefront. Joe Bradley is an active practice owner. biodynamic hematogel stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.